For the roughly 80 million people worldwide living with glaucoma, daily life often means watching the world slowly close in.

From billionaire-backed biotech to promising animal studies, this early trial will test whether partial reprogramming can ...

India, April 13 -- Life Biosciences, a clinical-stage biotechnology company focused on reversing diseases of aging, has ...

Neovascular age-related macular degeneration (nAMD) is a progressive eye disease characterized by choroidal neovascularization and subretinal hemorrhage and exudation, leading to vision impairment.